Wójcik-Pszczoła, K.; Chłoń-Rzepa, G.; Jankowska, A.; Ferreira, B.; Koczurkiewicz-Adamczyk, P.; Pękala, E.; Wyska, E.; Pociecha, K.; Gosens, R.
Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation. Pharmaceuticals 2022, 15, 423.
https://doi.org/10.3390/ph15040423
AMA Style
Wójcik-Pszczoła K, Chłoń-Rzepa G, Jankowska A, Ferreira B, Koczurkiewicz-Adamczyk P, Pękala E, Wyska E, Pociecha K, Gosens R.
Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation. Pharmaceuticals. 2022; 15(4):423.
https://doi.org/10.3390/ph15040423
Chicago/Turabian Style
Wójcik-Pszczoła, Katarzyna, Grażyna Chłoń-Rzepa, Agnieszka Jankowska, Bruno Ferreira, Paulina Koczurkiewicz-Adamczyk, Elżbieta Pękala, Elżbieta Wyska, Krzysztof Pociecha, and Reinoud Gosens.
2022. "Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation" Pharmaceuticals 15, no. 4: 423.
https://doi.org/10.3390/ph15040423
APA Style
Wójcik-Pszczoła, K., Chłoń-Rzepa, G., Jankowska, A., Ferreira, B., Koczurkiewicz-Adamczyk, P., Pękala, E., Wyska, E., Pociecha, K., & Gosens, R.
(2022). Pan-Phosphodiesterase Inhibitors Attenuate TGF-β-Induced Pro-Fibrotic Phenotype in Alveolar Epithelial Type II Cells by Downregulating Smad-2 Phosphorylation. Pharmaceuticals, 15(4), 423.
https://doi.org/10.3390/ph15040423